Executive Summary
VA awarded SoldierPoint Digital Health a $237.7M obligated Delivery Order (potential $862.8M with options) for IT architecture and app development, signaling strong demand in VA digital health services. No outlays yet but 19 subawards at $58.9M indicate active subcontracting. Upside hinges on option exercises extending to 2029; monitor for revenue recognition delays.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Tracking the trend? Catch up on the prior VA Healthcare & Services Contracts digest from March 27, 2026.
Investment Signals (1)
- Massive VA IT Contract Win (HIGH)▲
SoldierPoint secured $237.7M obligated value (ceiling $862.8M) via full/open competition for critical VA systems design services.
Risk Flags (2)
- Execution [HIGH RISK]▼
Firm fixed price exposes to cost overruns over 2-5 year period; $0 outlays delays revenue.
- Execution [MEDIUM RISK]▼
Dependency on 19 subawards totaling $58.9M risks subcontractor delays.
Opportunities (2)
- ◆
Option exercises could unlock additional $625M from current $237.7M obligation.
- ◆
Potential extension to 2029-09-06 beyond current 2026 end date.
Sector Themes (1)
- ◆
Large-scale award for NAICS 541512 services underscores VA prioritization of architecture/app development amid healthcare digitization.
Watch List (1)
- 👁
{"entity"=>"SoldierPoint Digital Health, LLC", "reason"=>"$862.8M ceiling with $237.7M start positions for multi-year VA revenue; subawards signal scale.", "trigger"=>"first outlays or option exercises"}
Get daily alerts with 1 investment signals, 2 risk alerts, 2 opportunities and full AI analysis of all 1 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: VA Healthcare & Services Contracts
🇺🇸 More from United States
View all →May 27, 2026
US Pre-Market SEC Filings Roundup — May 27, 2026
US Pre-Market SEC Filings Roundup
May 27, 2026
S&P 500 Technology Sector SEC Filings — May 27, 2026
S&P 500 Technology Sector SEC Filings
May 27, 2026
Orphan Drug Approvals — May 27, 2026
Orphan Drug Approvals
May 27, 2026
Big Pharma Approvals — May 27, 2026
Big Pharma Approvals